Arriving in the arena of excess body fat management, retatrutide presents a unique method. Unlike many current medications, retatrutide functions as a dual agonist, simultaneously affecting both GLP-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic hormone (GIP) sensors. The concurrent engagement encourages several helpful effects, like b